Faizan Ahmad, Anik Karan, Rashi Sharma, Navatha Shree Sharma, Vaishnavi Sundar, Richard Jayaraj, Sudip Mukherjee, Mark A DeCoster
Alzheimer's Disease (AD) patients experience diverse symptoms, including memory loss, cognitive impairment, behavioral abnormalities, mood changes, and mental issues. The fundamental objective of this review is to discuss novel therapeutic approaches, with special emphasis on recently approved marketed formulations for the treatment of AD, especially Aducanumab, the first FDA approved moiety that surpasses the blood-brain barrier (BBB) and reduces amyloid plaques in the brain, thereby reducing associated cognitive decline...
March 2024: Ageing Research Reviews